Judy Campagnari

I am a passionate healthcare and pharmaceutical strategist with proven experience creating “value from vision”. I have up to 28 years of pharmaceutical industry experience, the majority as a New Product Strategy and Planning professional.

I am currently Executive Director, Head of Global Patient Insights & Solutions (GPIS) for Alexion, AstraZeneca Rare Disease. My team is part of Alexion’s Patient Experience team, which also includes our country-level Patient Advocate colleagues. GPIS creates value for Alexion by partnering with external stakeholders (patients, caregivers, physicians, patient advocacy groups) to develop strategies and/or solutions that will accelerate results to patients living with rare disease. GPIS ensures that Alexion colleagues who work in all parts of the drug development timeline have a deep and empathetic understanding for the patient experience. Having that experience, Alexion colleagues can better identify strategies or solutions that deliver the therapies that patients, physicians, and other stakeholders need.

Prior to joining Alexion, I held several roles as a member of the Pfizer Inc. Commercial organisation.  Specifically, I was the New Products Commercial lead for three currently marketed products including a treatment for lung and breast cancer, rheumatoid arthritis, and an anticoagulant.  I received an AB degree in Biochemistry from Smith College (Northampton, MA), an MBA in Strategic Planning & Accounting from the Katz Graduate School of Business, University of Pittsburgh, and an Executive MBA Certificate in Strategic Finance from the Harvard Business School.